Registry for elderly inflammatory bowel disease patients

Registry for elderly inflammatory bowel disease patients - Elderly IBD Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052403

Enrollment

3000

Registered

2023-10-04

Start date

2024-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease (IBD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients aged 75 years or older who have been diagnosed with IBD according to the diagnostic criteria of the Intractable Disease Research Group supervised by the Ministry of Health, Labor and Welfare. 2) Patients who have given written consent to participate in the study

Exclusion criteria

Exclusion criteria: 1) Patients who are judged to be inappropriate as subjects by the researcher's judgment

Design outcomes

Primary

Measure	Time frame
1) Name and contact information 2) Date of birth, gender 3) Diagnosis name 4) Diagnosis status 5) Certification as a designated intractable disease patient 6) Month and year of onset 7) Date of diagnosis 8) Height 9) Weight 10) IBD family history 11) Smoking history 12) Drinking history 13) Scope of disease 14) Disease type (Crohn's disease only) 15) Concomitant diseases 16) Extraintestinal complications [arthralgia, erythema nodosum, episcleritis, pyoderma gangrenosum, uveitis, peripheral spondyloarthritis, axial spondyloarthritis, primary sclerosing cholangitis, others] (including past cases) 17) History of hospitalization due to IBD 18) Treatment history 19) Cohabitant 20) Nursing care insurance certification 21) Frailty (basic checklist) 22) Oral frailty (8 items) 23) History of malignant tumor 24) History of falls/fractures 25) Concomitant drugs 26) Polypharmacy 27) History of thrombosis 28) Owning a smartphone 29) Current number of teeth 30) Medical institution name 31) Clinical department, 32) Health status (EQ-5D-5L), 33) Outcome	—

Measure

Time frame

1) Name and contact information 2) Date of birth, gender 3) Diagnosis name 4) Diagnosis status 5) Certification as a designated intractable disease patient 6) Month and year of onset 7) Date of diagnosis 8) Height 9) Weight 10) IBD family history 11) Smoking history 12) Drinking history 13) Scope of disease 14) Disease type (Crohn's disease only) 15) Concomitant diseases 16) Extraintestinal complications [arthralgia, erythema nodosum, episcleritis, pyoderma gangrenosum, uveitis, peripheral spondyloarthritis, axial spondyloarthritis, primary sclerosing cholangitis, others] (including past cases) 17) History of hospitalization due to IBD 18) Treatment history 19) Cohabitant 20) Nursing care insurance certification 21) Frailty (basic checklist) 22) Oral frailty (8 items) 23) History of malignant tumor 24) History of falls/fractures 25) Concomitant drugs 26) Polypharmacy 27) History of thrombosis 28) Owning a smartphone 29) Current number of teeth 30) Medical institution name 31) Clinical department, 32) Health status (EQ-5D-5L), 33) Outcome

—

Countries

Japan

Contacts

Public ContactTaku Kobayashi

Kitasato University Kitasato Institute Hospital Center for Advanced IBD Research and Treatment

drkobataku@gmail.com0357916487

Outcome results